Company
Nanoform Finland Oyj
Headquarters: Helsinki, Finland
Employees: 125
CEO: Prof. Edward Olof Haeggstrom
Market Cap
€127.8 Million
EUR as of Jan. 1, 2024
US$141.2 Million
Nanoform Finland Oyj Categories
Finland Healthcare BiotechnologyFinland Healthcare Finland Biotechnology
Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $461.52 B |
| Vertex Pharmaceuticals Incorporated | $107.23 B |
| Regeneron Pharmaceuticals, Inc. | $100.01 B |
| CSL Limited | $94.74 B |
| Marinomed Biotech AG | $73.23 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Nanoform Finland Oyj provides nanotechnology and drug particle engineering services for the pharmaceutical industry in Finland and internationally. The company provides nanoparticle production services using its proprietary controlled expansion of supercritical solutions technology that enables clients in the creation of active pharmaceutical ingredients nanoparticles directly from solution. The company was founded in 2008 and is headquartered in Helsinki, Finland.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Nanoform Finland Oyj has the following listings and related stock indices.
Stock: OMXH: NANOFH wb_incandescent
Stock: FSX: 4YL wb_incandescent